1. Home
  2. CVNA vs NTRA Comparison

CVNA vs NTRA Comparison

Compare CVNA & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVNA
  • NTRA
  • Stock Information
  • Founded
  • CVNA 2012
  • NTRA 2003
  • Country
  • CVNA United States
  • NTRA United States
  • Employees
  • CVNA N/A
  • NTRA N/A
  • Industry
  • CVNA Other Specialty Stores
  • NTRA Medical Specialities
  • Sector
  • CVNA Consumer Discretionary
  • NTRA Health Care
  • Exchange
  • CVNA Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • CVNA 25.6B
  • NTRA 20.9B
  • IPO Year
  • CVNA 2017
  • NTRA 2015
  • Fundamental
  • Price
  • CVNA $267.92
  • NTRA $151.95
  • Analyst Decision
  • CVNA Buy
  • NTRA Strong Buy
  • Analyst Count
  • CVNA 18
  • NTRA 17
  • Target Price
  • CVNA $272.28
  • NTRA $178.41
  • AVG Volume (30 Days)
  • CVNA 3.8M
  • NTRA 1.1M
  • Earning Date
  • CVNA 05-07-2025
  • NTRA 05-08-2025
  • Dividend Yield
  • CVNA N/A
  • NTRA N/A
  • EPS Growth
  • CVNA 87.85
  • NTRA N/A
  • EPS
  • CVNA 2.97
  • NTRA N/A
  • Revenue
  • CVNA $14,844,000,000.00
  • NTRA $1,831,000,000.00
  • Revenue This Year
  • CVNA $24.48
  • NTRA $15.45
  • Revenue Next Year
  • CVNA $18.06
  • NTRA $18.43
  • P/E Ratio
  • CVNA $96.15
  • NTRA N/A
  • Revenue Growth
  • CVNA 32.23
  • NTRA 51.50
  • 52 Week Low
  • CVNA $97.55
  • NTRA $92.14
  • 52 Week High
  • CVNA $293.62
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • CVNA 63.58
  • NTRA 49.96
  • Support Level
  • CVNA $253.49
  • NTRA $153.40
  • Resistance Level
  • CVNA $293.62
  • NTRA $159.15
  • Average True Range (ATR)
  • CVNA 12.48
  • NTRA 6.36
  • MACD
  • CVNA 3.97
  • NTRA 0.65
  • Stochastic Oscillator
  • CVNA 71.48
  • NTRA 39.44

About CVNA Carvana Co.

Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: